Generic name:hyaluronidase and rituximab [ HYE-al-ure-ON-i-dase ]
Drug class:CD20 monoclonal antibodies
What is Rituxan Hycela?
Rituxan Hycela contains a combination of hyaluronidase and rituximab. Hyaluronidase is a genetically designed protein. Rituximab is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Rituxan Hycela is used to treat follicular lymphoma, diffuse large B-cell lymphoma, or chronic lymphocytic leukemia.
Rituxan Hycela is sometimes used together with other cancer medicines.
Rituxan Hycela is usually given only after you have received at least 1 injection of rituximab alone.
Warnings
Do not use Rituxan Hycela if you are pregnant. Avoid getting pregnant for at least 12 months after you stop using this medicine.
Rituxan Hycela may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have problems with speech, thought, vision, or muscle movement.
If you've ever had hepatitis B, using Rituxan Hycela can cause this virus to become active or get worse.
Severe skin problems can also occur during treatment with Rituxan Hycela. Call your doctor if you have painful skin or mouth sores, or a severe skin rash with blistering, peeling, or pus.
Some side effects may occur during the injection or within 24 hours afterward. Tell your caregiver right away if you feel itchy, dizzy, weak, light-headed, short of breath, chilled, feverish, or if you have chest pain, wheezing, a sudden cough, or pounding heartbeats or fluttering in your chest.
